Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

State of the Art of Materials Science and Engineering in Italy.

Materials (Basel, Switzerland)·2026
Same author

RUNX2 regulates aberrant expression of collagen genes in keloid fibroblasts.

The Journal of investigative dermatology·2025
Same author

Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.

Pediatric dermatology·2025
Same author

Broadening the mutational spectrum of ASAH1, as a susceptibility gene for keloids.

Journal of human genetics·2025
Same author

Advanced nanofibers integrating vitamin D3 and cerium oxide nanoparticles for enhanced diabetic wound healing: Co-electrospun silk fibroin-collagen and chitosan-PVA systems.

International journal of biological macromolecules·2025
Same author

Synergistic effects of incorporated additives in multifunctional dressings for chronic wound healing: An updated comprehensive review.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2024

Related Experiment Video

Updated: Sep 3, 2025

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering
07:14

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering

Published on: July 27, 2022

3.8K

Hydroxyapatite Nanoparticles for Improved Cancer Theranostics.

Saeid Kargozar1, Sahar Mollazadeh2, Farzad Kermani2

  • 1Tissue Engineering Research Group (TERG), Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.

Journal of Functional Biomaterials
|July 27, 2022
PubMed
Summary

Hydroxyapatite nanoparticles (HAp NPs) show promise in cancer therapy by enabling targeted drug delivery and inhibiting cancer cell growth. Further research into HAp NPs for cancer theranostics could lead to advanced treatments.

Keywords:
bioceramicscancer treatmenthydroxyapatitenanomaterials

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.2K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.1K

Related Experiment Videos

Last Updated: Sep 3, 2025

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering
07:14

Synthesis of Graphene-Hydroxyapatite Nanocomposites for Potential Use in Bone Tissue Engineering

Published on: July 27, 2022

3.8K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.2K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.1K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Oncology

Background:

  • Hydroxyapatite nanoparticles (HAp NPs) are explored for advanced cancer therapy beyond bone tissue engineering.
  • Their unique chemical structure facilitates sustained and targeted delivery of anticancer drugs, potentially reducing side effects.
  • HAp NPs can be modified for enhanced cancer cell targeting and inhibition of metastasis.

Purpose of the Study:

  • To review the applications of HAp NPs in cancer theranostics.
  • To highlight the potential of HAp NPs in drug delivery, cancer cell inhibition, and imaging.
  • To discuss current limitations and future research directions for HAp NP-based cancer treatments.

Main Methods:

  • Review of current literature on HAp NP applications in cancer therapy and diagnosis.
  • Analysis of HAp NP properties for drug loading, targeted delivery, and theranostic capabilities.
  • Examination of HAp NP use in scaffolds for tissue regeneration post-cancer treatment.

Main Results:

  • HAp NPs offer a versatile platform for sustained drug release and targeted cancer therapy.
  • Surface modifications enable smart targeting and killing of cancer cells with minimal impact on healthy cells.
  • Superparamagnetic HAp NPs show potential for in vivo imaging and early cancer detection.
  • HAp NPs are being investigated for fabricating scaffolds for cancerous tissue treatment and regeneration.

Conclusions:

  • HAp NPs represent a promising theranostic agent for improved cancer treatment strategies.
  • Further research is needed to overcome current limitations and fully realize the potential of HAp NPs in oncology.
  • HAp NP-based approaches offer new avenues for developing effective and less toxic cancer therapies.